Sarah Cavanaugh | Senior Vice President, Corporate Affairs and Administration |
Anthony Marucci | Founder, President, Chief Executive Officer and Director |
Tibor Keler | Founder, Executive Vice President and Chief Scientific Officer |
Sam Martin | Senior Vice President and Chief Financial Officer |
Joseph Pantginis | H.C. Wainwright & Co. |
Boris Peaker | Cowen and Company |
Stephen Brozak | WBB Securities, LLC |
Good day, ladies and gentlemen, and welcome to the Celldex Therapeutics Mid-Year 2018 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, today's program is being recorded. And I would like to introduce your host for today's program, Sarah Cavanaugh.